It’s not just hydroxychloroquine. There are many drugs that can be used, as we have seen this week. … There is a whole new repertoire … of drugs that work in early treatment.
A leading U.S. medical journal announced the medicine hydroxychloroquine can effectively treat the coronavirus.
Source: AAPS Author: Peter McCullough From the Association of American Physicians and Surgeons: It is our honor to bring Dr. McCullough back to “Doctors Are
Source: Reviews in Cardiovascular Medicine Peter A. McCullough, Paul E. Alexander, Robin Armstrong, Cristian Arvinte, Alan F. Bain, Richard P. Bartlett, Robert L. Berkowitz, Andrew
Source: AS.com A study by ISGlobal and the Clínica Universidad de Navarra points to a significant reduction in viral load in those who received ivermectin.
Source: ivmmeta.com Figure 1. A. Random effects meta-analysis excluding late treatment. Simplified dosages are shown for comparison, these are the total dose in the first two days
Source: Research Gate SHOUMAN WM1, HEGAZY AA2, NAFAE RM3, RAGAB ME4, SAMRA SR5, ANAS D6, AL-MAHROUKY TH7, SILEEM AE8DO – 10.7860/JCDR/2020/46795.0000 INTRODUCTION An outbreak of
Source: Ala Arena In a press conference, the Minister of Health, Mario Kohan, informed that the drug will be used as a treatment against the
The FLCCC Alliance was organized in March, 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness.
Source: Quadrant Online Author: Robert Clancy Robert Clancy: The author is Emeritus Professor of Pathology at the University of Newcastle Medical School. He is a
In this study of COVID-19, for infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization
A lupus cohort study from British Columbia, Canada has shown that medication adherence with hydroxychloroquine (HCQ) is associated with a 71% to 83% lower mortality.
However, analysis concluded that the use of Ivermectin in the management of COVID-19 infections is associated with faster time to viral clearance, shorter duration of hospitalisation, and higher rates of clinical recovery.”
Maintaining an average hydroxychloroquine whole blood level above 1,068 ng/mL significantly reduced the risk of thrombosis in adults with systemic lupus.
HCQ is effective for COVID-19. The chance that an ineffective treatment generated results as positive as the 187 studies to date is 1 in 5 quadrillion (p = 0.00000000000000019).
Source: PubMed Petri M, Konig MF, Li J, Goldman DW. Higher Hydroxychloroquine Blood Levels Are Associated with Reduced Thrombosis Risk in Systemic Lupus Erythematosus. Arthritis
Hydroxychloroquine is an effective molecule against COVID-19 infection, many RCTs and observational studies, affirmed the benefits on virological clearance.
No cases of sudden death were observed. From publication, we have treated 3,119 patients with HCQ-AZ for at least three days.
Early SMDT (sequenced multidrug therapy) should be a standard practice in high risk & severely symptomatic acute COVID-19 patients at the onset of illness.
The early use of
hydroxychloroquine decreased the improvement time
and the duration of COVID-19 detection in throat and
stool swabs.
Source: Covid Medical Network Presented by: Dr Eamonn Mathieson and Ben Bornstein EARLY COVID TREATMENTS: Guest Speaker with the Covid Medial Network – Dr Ananda
This report forms the scientific basis for the decision to authorise hydroxychloroquine in the treatment of Covid-19 in the early phase of the disease.
Source: Filipe Rafaeli Author: Filipe Rafaeli Read PART ONE here Scientists have already discovered what to do for the hydroxychloroquine to work also in critically
Source: Filipe Rafaeli Author: Filipe Rafaeli If you don’t want to die in this pandemic, read it to the end! Here I do a historical
Source: Collective Evolution Author: Arjun Walia IN BRIEF The Facts: Dr. Harvey Risch, MD, Ph.D., Yale Professor of Epidemiology and Public Health provides evidence-based testimony
Appearing as a witness Tuesday morning before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on Ivermectin.
Source: HCQMeta.com HCQ is effective for COVID-19 when used early: meta-analysis of 156 studies (Version 28, December 4, 2020) • HCQ is effective for COVID-19.
Source: Research Square. Augusto Di Castelnuovo, Mediterranea Cardiocentro, NapoliSimona Costanzo, Department of Epidemiology and Prevention, IRCCS Neuromed, PozzilliAntonio Cassone, Polo della genomica, genetica e biologia,
Source: MedRxIV David M. Wiseman, Pierre Kory, Samir A Saidi, Dan Mazzucco doi: https://doi.org/10.1101/2020.11.29.20235218 Abstract BACKGROUND A recent trial (NCT04308668) found that post-exposure prophylaxis with hydroxychloroquine (HCQ) was associated with a reduced incidence
Chloroquine / hydroxychloroquine could treat COVID-19 infection
Source: The Blaze Author: CHRIS PANDOLFO A peer-reviewed study analyzing the effectiveness of a triple drug cocktail including hydroxychloroquine in treating COVID-19 patients found that the treatment
Results obtained in the prophylaxis of Q fever indicate that chloroquine/hydroxychloroquine can be successfully used in the clinical management of infections other than malaria.
Source: Science Direct Tran Duc Anh Ly, Didier Zanini, Vincent Laforge, Sylvie Arlotto, Stephanie Gentile, Helene Mendizabal, Michael Finaud, David Morel, Olivier Quenette, Priscilla Malfuson-Clot-Faybesse,
Source: Science Direct Eman Sheshah, Shaun Sabico, Rashed M. Albakr, Anmar A. Sultan, Khalaf S. Alghamdi, Khaled Al Madani, Hadil A. Alotair, Nasser M. Al-Daghri,Prevalence
Source: Science Direct Simova I, Vekov T, Krasnaliev J, Kornovski V, Bozhinov P,Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health care workers, New Microbesand
Source: News Max Author: By Brian Trusdell Photo: Getty The anti-malarial drug promoted by the US President as a treatment for COVID-19 — and derided by
We should learn from the countries that have been using the drug. The dramatic fall in death rates that occurred after hydroxychloroquine treatment was initiated in countries like India, Brazil and Ecuador can no longer be ignored. To do so, and to continue to interfere with a doctor’s right to prescribe HCQ to their patients, is reckless and immoral.
Of the whole study group (RA and SLE), 54% used hydroxychloroquine and 44% had QTc lengths of more than 440 milliseconds. They found that the adjusted QTc length among hydroxychloroquine users was comparable to those who did not use the drug.
Source: Journal of Marine Medical Society Date of Submission 23-Aug-2020 Date of Decision 18-Sep-2020 Date of Acceptance 29-Sep-2020 Date of Web Publication 06-Nov-2020 Correspondence Address:Vivek
Source: Science Direct Dr. Deba PrasadDhibarMD(Assistant Professor)aDr. NavneetAroraMD(Senior Resident)aDr. ArpitKakkarDNB(Senior Resident)aDr. NeerajSinglaMD(Assistant Professor)bDr. RitinMohindraMD(Assistant Professor)bDr. VikasSuriMD(Additional Professor)bDr. AshishBhallaMD(Professor)bDr. NavneetSharmaMD(Professor)bDr. Mini PSinghMD(Professor)cDr. AjayPrakashPhd(Assistant Professor)dDr. LakshmiPVMMD(Professor)eDr. BikashMedhiMD(Professor)d
